Molecular Genetics

Edited by: Steven Benowitz ALLELIC TWINS: Jackson-Weiss and Crouzon syndromes are both caused by FGFR2 mutation, notes Johns Hopkins researcher Ethylin Jabs. E.W. Jabs, X. Li, A.F. Scott, G. Meyers, W. Chen, M. Eccles, J.I. Mao, L.R. Charnas, C.E. Jackson, M. Jaye, "Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2," Nature Genetics, 8:275-9, 1994. (Cited in nearly 70 publications through October 1996) Comments by Ethylin Wang Jabs, Johns H

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Edited by: Steven Benowitz


ALLELIC TWINS: Jackson-Weiss and Crouzon syndromes are both caused by FGFR2 mutation, notes Johns Hopkins researcher Ethylin Jabs.
E.W. Jabs, X. Li, A.F. Scott, G. Meyers, W. Chen, M. Eccles, J.I. Mao, L.R. Charnas, C.E. Jackson, M. Jaye, "Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2," Nature Genetics, 8:275-9, 1994. (Cited in nearly 70 publications through October 1996) Comments by Ethylin Wang Jabs, Johns Hopkins University School of Medicine, Baltimore

Mutations in a group of proteins known as fibroblast growth factor receptors 2 (FGFR2) have been found in patients with Jackson-Weiss syndrome, in which the skull, face, and feet may be deformed, and another similar inherited disorder, Crouzon syndrome. One of the hallmarks of both diseases is craniosynostosis, in which the skull bones fuse prematurely, causing abnormally shaped skulls. The condition occurs in one in 3,000 newborns.

FGFRs are involved ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies